Industry Research Reports
Part 1
Part 2
Part 3
Part 5
Home > Reports >
Pharma & Healthcare
>
Global Calcimimetic Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application
Global Calcimimetic Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application
-
Description
- Table of Contents
- Table of Figures
- PDF Download
-
Description
- Table of Contents
- Table of Figures
- PDF Download
A calcimimetic is a pharmaceutical drug that mimics the action of calcium on tissues, by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. Calcimimetics are used to treat secondary hyperparathyroidism (SHPT). Calcimimetic report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Calcimimetic market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The parathyroid gland is an essential gland for human life, and SHPT is a common and serious decompensation disease in patients with chronic kidney disease receiving dialysis treatment, and it is one of the important manifestations of mineral metabolism disorders. According to the 2012 China Epidemiological Survey, the number of patients with middle and end-stage renal disease in China is about 2 million, the dialysis rate is less than 20%, and the conversion rate of SHPT in patients with mineral and bone metabolic disorders (CKD-MBD) is close to 50%. . The dialysis rate is 90% in developed countries (United States, Europe, Japan). Based on this, it can be predicted that in the future, the number of SHPT people will release a large growth space with the improvement of the diagnosis, detection and treatment of chronic kidney disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Calcimimetic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Amgen
Ono Pharmaceutical
Aurobindo Pharma
Roche Holding AG
Lilly
Merck & Co., Inc.
Johnsons & Johnsons
Bristol Myers Squibb
Accord Healthcare , Inc.
Alkem Labs
Viatris
Teva Pharmaceutical Industries Ltd
Segment by Type
Cinacalcet
Etelcalcetide
Evocalcet
Segment by Application
Hospital
Clinic
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Calcimimetic market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Calcimimetic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Calcimimetic industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Calcimimetic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Calcimimetic introduction, etc. Calcimimetic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Calcimimetic market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch. 1 Calcimimetic Market Overview
1.1 Calcimimetic Product Overview
1.2 Calcimimetic Market Segment by Type
1.2.1 Cinacalcet
1.2.2 Etelcalcetide
1.2.3 Evocalcet
1.3 Global Calcimimetic Market Size by Type
1.3.1 Global Calcimimetic Market Size Overview by Type (2018-2029)
1.3.2 Global Calcimimetic Historic Market Size Review by Type (2018-2023)
1.3.3 Global Calcimimetic Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Calcimimetic Sales Breakdown by Type (2018-2023)
1.4.2 Europe Calcimimetic Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Calcimimetic Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Calcimimetic Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Calcimimetic Sales Breakdown by Type (2018-2023)
2.1 Global Top Players by Calcimimetic Sales (2018-2023)
2.2 Global Top Players by Calcimimetic Revenue (2018-2023)
2.3 Global Top Players by Calcimimetic Price (2018-2023)
2.4 Global Top Manufacturers Calcimimetic Manufacturing Base Distribution, Sales Area, Product Type
2.5 Calcimimetic Market Competitive Situation and Trends
2.5.1 Calcimimetic Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Calcimimetic Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Calcimimetic as of 2022)
2.7 Date of Key Manufacturers Enter into Calcimimetic Market
2.8 Key Manufacturers Calcimimetic Product Offered
2.9 Mergers & Acquisitions, Expansion
3.1 Global Calcimimetic Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Calcimimetic Historic Market Size by Region
3.2.1 Global Calcimimetic Sales in Volume by Region (2018-2023)
3.2.2 Global Calcimimetic Sales in Value by Region (2018-2023)
3.2.3 Global Calcimimetic Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Calcimimetic Forecasted Market Size by Region
3.3.1 Global Calcimimetic Sales in Volume by Region (2024-2029)
3.3.2 Global Calcimimetic Sales in Value by Region (2024-2029)
3.3.3 Global Calcimimetic Sales (Volume & Value), Price and Gross Margin (2024-2029)
4.1 Calcimimetic Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Calcimimetic Market Size by Application
4.2.1 Global Calcimimetic Market Size Overview by Application (2018-2029)
4.2.2 Global Calcimimetic Historic Market Size Review by Application (2018-2023)
4.2.3 Global Calcimimetic Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Calcimimetic Sales Breakdown by Application (2018-2023)
4.3.2 Europe Calcimimetic Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Calcimimetic Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Calcimimetic Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Calcimimetic Sales Breakdown by Application (2018-2023)
5.1 North America Calcimimetic Historic Market Size by Country
5.1.1 North America Calcimimetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Calcimimetic Sales in Volume by Country (2018-2023)
5.1.3 North America Calcimimetic Sales in Value by Country (2018-2023)
5.2 North America Calcimimetic Forecasted Market Size by Country
5.2.1 North America Calcimimetic Sales in Volume by Country (2024-2029)
5.2.2 North America Calcimimetic Sales in Value by Country (2024-2029)
6.1 Europe Calcimimetic Historic Market Size by Country
6.1.1 Europe Calcimimetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Calcimimetic Sales in Volume by Country (2018-2023)
6.1.3 Europe Calcimimetic Sales in Value by Country (2018-2023)
6.2 Europe Calcimimetic Forecasted Market Size by Country
6.2.1 Europe Calcimimetic Sales in Volume by Country (2024-2029)
6.2.2 Europe Calcimimetic Sales in Value by Country (2024-2029)
7.1 Asia-Pacific Calcimimetic Historic Market Size by Region
7.1.1 Asia-Pacific Calcimimetic Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Calcimimetic Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Calcimimetic Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Calcimimetic Forecasted Market Size by Region
7.2.1 Asia-Pacific Calcimimetic Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Calcimimetic Sales in Value by Region (2024-2029)
8.1 Latin America Calcimimetic Historic Market Size by Country
8.1.1 Latin America Calcimimetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Calcimimetic Sales in Volume by Country (2018-2023)
8.1.3 Latin America Calcimimetic Sales in Value by Country (2018-2023)
8.2 Latin America Calcimimetic Forecasted Market Size by Country
8.2.1 Latin America Calcimimetic Sales in Volume by Country (2024-2029)
8.2.2 Latin America Calcimimetic Sales in Value by Country (2024-2029)
9.1 Middle East and Africa Calcimimetic Historic Market Size by Country
9.1.1 Middle East and Africa Calcimimetic Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Calcimimetic Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Calcimimetic Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Calcimimetic Forecasted Market Size by Country
9.2.1 Middle East and Africa Calcimimetic Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Calcimimetic Sales in Value by Country (2024-2029)
10.1 Amgen
10.1.1 Amgen Company Information
10.1.2 Amgen Introduction and Business Overview
10.1.3 Amgen Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Amgen Calcimimetic Products Offered
10.1.5 Amgen Recent Development
10.2 Ono Pharmaceutical
10.2.1 Ono Pharmaceutical Company Information
10.2.2 Ono Pharmaceutical Introduction and Business Overview
10.2.3 Ono Pharmaceutical Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Ono Pharmaceutical Calcimimetic Products Offered
10.2.5 Ono Pharmaceutical Recent Development
10.3 Aurobindo Pharma
10.3.1 Aurobindo Pharma Company Information
10.3.2 Aurobindo Pharma Introduction and Business Overview
10.3.3 Aurobindo Pharma Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Aurobindo Pharma Calcimimetic Products Offered
10.3.5 Aurobindo Pharma Recent Development
10.4 Roche Holding AG
10.4.1 Roche Holding AG Company Information
10.4.2 Roche Holding AG Introduction and Business Overview
10.4.3 Roche Holding AG Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Roche Holding AG Calcimimetic Products Offered
10.4.5 Roche Holding AG Recent Development
10.5 Lilly
10.5.1 Lilly Company Information
10.5.2 Lilly Introduction and Business Overview
10.5.3 Lilly Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Lilly Calcimimetic Products Offered
10.5.5 Lilly Recent Development
10.6 Merck & Co., Inc.
10.6.1 Merck & Co., Inc. Company Information
10.6.2 Merck & Co., Inc. Introduction and Business Overview
10.6.3 Merck & Co., Inc. Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Merck & Co., Inc. Calcimimetic Products Offered
10.6.5 Merck & Co., Inc. Recent Development
10.7 Johnsons & Johnsons
10.7.1 Johnsons & Johnsons Company Information
10.7.2 Johnsons & Johnsons Introduction and Business Overview
10.7.3 Johnsons & Johnsons Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Johnsons & Johnsons Calcimimetic Products Offered
10.7.5 Johnsons & Johnsons Recent Development
10.8 Bristol Myers Squibb
10.8.1 Bristol Myers Squibb Company Information
10.8.2 Bristol Myers Squibb Introduction and Business Overview
10.8.3 Bristol Myers Squibb Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Bristol Myers Squibb Calcimimetic Products Offered
10.8.5 Bristol Myers Squibb Recent Development
10.9 Accord Healthcare , Inc.
10.9.1 Accord Healthcare , Inc. Company Information
10.9.2 Accord Healthcare , Inc. Introduction and Business Overview
10.9.3 Accord Healthcare , Inc. Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Accord Healthcare , Inc. Calcimimetic Products Offered
10.9.5 Accord Healthcare , Inc. Recent Development
10.10 Alkem Labs
10.10.1 Alkem Labs Company Information
10.10.2 Alkem Labs Introduction and Business Overview
10.10.3 Alkem Labs Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Alkem Labs Calcimimetic Products Offered
10.10.5 Alkem Labs Recent Development
10.11 Viatris
10.11.1 Viatris Company Information
10.11.2 Viatris Introduction and Business Overview
10.11.3 Viatris Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Viatris Calcimimetic Products Offered
10.11.5 Viatris Recent Development
10.12 Teva Pharmaceutical Industries Ltd
10.12.1 Teva Pharmaceutical Industries Ltd Company Information
10.12.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.12.3 Teva Pharmaceutical Industries Ltd Calcimimetic Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Teva Pharmaceutical Industries Ltd Calcimimetic Products Offered
10.12.5 Teva Pharmaceutical Industries Ltd Recent Development
11.1 Calcimimetic Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Calcimimetic Industrial Chain Analysis
11.4 Calcimimetic Market Dynamics
11.4.1 Calcimimetic Industry Trends
11.4.2 Calcimimetic Market Drivers
11.4.3 Calcimimetic Market Challenges
11.4.4 Calcimimetic Market Restraints
12.1 Sales Channel
12.2 Calcimimetic Distributors
12.3 Calcimimetic Downstream Customers
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Major Company of Cinacalcet
Table 2. Major Company of Etelcalcetide
Table 3. Major Company of Evocalcet
Table 4. Global Calcimimetic Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Calcimimetic Sales by Type (2018-2023) & (K Units)
Table 6. Global Calcimimetic Sales Market Share in Volume by Type (2018-2023)
Table 7. Global Calcimimetic Sales by Type (2018-2023) & (US& Million)
Table 8. Global Calcimimetic Market Share in Value by Type (2018-2023)
Table 9. Global Calcimimetic Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Calcimimetic Sales by Type (2024-2029) & (K Units)
Table 11. Global Calcimimetic Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Calcimimetic Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Calcimimetic Sales Market Share in Value by Type (2024-2029)
Table 14. Global Calcimimetic Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Calcimimetic Sales by Type (2018-2023) & (K Units)
Table 16. North America Calcimimetic Sales by Type (2018-2023) & (US$ Million)
Table 17. Europe Calcimimetic Sales (K Units) by Type (2018-2023)
Table 18. Europe Calcimimetic Sales by Type (2018-2023) & (US$ Million)
Table 19. Asia-Pacific Calcimimetic Sales (K Units) by Type (2018-2023)
Table 20. Asia-Pacific Calcimimetic Sales by Type (2018-2023) & (US$ Million)
Table 21. Latin America Calcimimetic Sales (K Units) by Type (2018-2023)
Table 22. Latin America Calcimimetic Sales by Type (2018-2023) & (US$ Million)
Table 23. Middle East and Africa Calcimimetic Sales (K Units) by Type (2018-2023)
Table 24. Middle East and Africa Calcimimetic Sales by Type (2018-2023) & (US$ Million)
Table 25. Global Calcimimetic Sales by Company (2018-2023) & (K Units)
Table 26. Global Calcimimetic Sales Share by Company (2018-2023)
Table 27. Global Calcimimetic Revenue by Company (2018-2023) & (US$ Million)
Table 28. Global Calcimimetic Revenue Share by Company (2018-2023)
Table 29. Global Market Calcimimetic Price by Company (2018-2023) & (US$/Unit)
Table 30. Global Calcimimetic Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Calcimimetic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Calcimimetic as of 2022)
Table 33. Date of Key Manufacturers Enter into Calcimimetic Market
Table 34. Key Manufacturers Calcimimetic Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Calcimimetic Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Calcimimetic Sales by Region (2018-2023) & (K Units)
Table 38. Global Calcimimetic Sales Market Share in Volume by Region (2018-2023)
Table 39. Global Calcimimetic Sales by Region (2018-2023) & (US$ Million)
Table 40. Global Calcimimetic Sales Market Share in Value by Region (2018-2023)
Table 41. Global Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 42. Global Calcimimetic Sales by Region (2024-2029) & (K Units)
Table 43. Global Calcimimetic Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Calcimimetic Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Calcimimetic Sales Market Share in Value by Region (2024-2029)
Table 46. Global Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Calcimimetic Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Calcimimetic Sales by Application (2018-2023) & (K Units)
Table 49. Global Calcimimetic Sales Market Share in Volume by Application (2018-2023)
Table 50. Global Calcimimetic Sales by Application (2018-2023) & (US$ Million)
Table 51. Global Calcimimetic Sales Market Share in Value by Application (2018-2023)
Table 52. Global Calcimimetic Price by Application (2018-2023) & (US$/Unit)
Table 53. Global Calcimimetic Sales by Application (2024-2029) & (K Units)
Table 54. Global Calcimimetic Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Calcimimetic Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Calcimimetic Sales Market Share in Value by Application (2024-2029)
Table 57. Global Calcimimetic Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Calcimimetic Sales by Application (2018-2023) (K Units)
Table 59. North America Calcimimetic Sales by Application (2018-2023) & (US$ Million)
Table 60. Europe Calcimimetic Sales by Application (2018-2023) (K Units)
Table 61. Europe Calcimimetic Sales by Application (2018-2023) & (US$ Million)
Table 62. Asia-Pacific Calcimimetic Sales by Application (2018-2023) (K Units)
Table 63. Asia-Pacific Calcimimetic Sales by Application (2018-2023) & (US$ Million)
Table 64. Latin America Calcimimetic Sales by Application (2018-2023) (K Units)
Table 65. Latin America Calcimimetic Sales by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Calcimimetic Sales by Application (2018-2023) (K Units)
Table 67. Middle East and Africa Calcimimetic Sales by Application (2018-2023) & (US$ Million)
Table 68. North America Calcimimetic Sales by Country (2018-2023) & (K Units)
Table 69. North America Calcimimetic Sales Market Share in Volume by Country (2018-2023)
Table 70. North America Calcimimetic Sales by Country (2018-2023) & (US$ Million)
Table 71. North America Calcimimetic Sales Market Share in Value by Country (2018-2023)
Table 72. North America Calcimimetic Sales by Country (2024-2029) & (K Units)
Table 73. North America Calcimimetic Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Calcimimetic Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Calcimimetic Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Calcimimetic Sales by Country (2018-2023) & (K Units)
Table 77. Europe Calcimimetic Sales Market Share in Volume by Country (2018-2023)
Table 78. Europe Calcimimetic Sales by Country (2018-2023) & (US$ Million)
Table 79. Europe Calcimimetic Sales Market Share in Value by Country (2018-2023)
Table 80. Europe Calcimimetic Sales by Country (2024-2029) & (K Units)
Table 81. Europe Calcimimetic Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Calcimimetic Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Calcimimetic Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Calcimimetic Sales by Region (2018-2023) & (K Units)
Table 85. Asia-Pacific Calcimimetic Sales Market Share in Volume by Region (2018-2023)
Table 86. Asia-Pacific Calcimimetic Sales by Region (2018-2023) & (US$ Million)
Table 87. Asia-Pacific Calcimimetic Sales Market Share in Value by Region (2018-2023)
Table 88. Asia-Pacific Calcimimetic Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Calcimimetic Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Calcimimetic Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Calcimimetic Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Calcimimetic Sales by Country (2018-2023) & (K Units)
Table 93. Latin America Calcimimetic Sales Market Share in Volume by Country (2018-2023)
Table 94. Latin America Calcimimetic Sales by Country (2018-2023) & (US$ Million)
Table 95. Latin America Calcimimetic Sales Market Share in Value by Country (2018-2023)
Table 96. Latin America Calcimimetic Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Calcimimetic Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Calcimimetic Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Calcimimetic Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Calcimimetic Sales by Country (2018-2023) & (K Units)
Table 101. Middle East and Africa Calcimimetic Sales Market Share in Volume by Country (2018-2023)
Table 102. Middle East and Africa Calcimimetic Sales by Country (2018-2023) & (US$ Million)
Table 103. Middle East and Africa Calcimimetic Sales Market Share in Value by Country (2018-2023)
Table 104. Middle East and Africa Calcimimetic Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Calcimimetic Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Calcimimetic Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Calcimimetic Sales Market Share in Value by Country (2024-2029)
Table 108. Amgen Company Information
Table 109. Amgen Introduction and Business Overview
Table 110. Amgen Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Amgen Calcimimetic Product
Table 112. Amgen Recent Development
Table 113. Ono Pharmaceutical Company Information
Table 114. Ono Pharmaceutical Introduction and Business Overview
Table 115. Ono Pharmaceutical Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Ono Pharmaceutical Calcimimetic Product
Table 117. Ono Pharmaceutical Recent Development
Table 118. Aurobindo Pharma Company Information
Table 119. Aurobindo Pharma Introduction and Business Overview
Table 120. Aurobindo Pharma Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Aurobindo Pharma Calcimimetic Product
Table 122. Aurobindo Pharma Recent Development
Table 123. Roche Holding AG Company Information
Table 124. Roche Holding AG Introduction and Business Overview
Table 125. Roche Holding AG Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Roche Holding AG Calcimimetic Product
Table 127. Roche Holding AG Recent Development
Table 128. Lilly Company Information
Table 129. Lilly Introduction and Business Overview
Table 130. Lilly Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Lilly Calcimimetic Product
Table 132. Lilly Recent Development
Table 133. Merck & Co., Inc. Company Information
Table 134. Merck & Co., Inc. Introduction and Business Overview
Table 135. Merck & Co., Inc. Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Merck & Co., Inc. Calcimimetic Product
Table 137. Merck & Co., Inc. Recent Development
Table 138. Johnsons & Johnsons Company Information
Table 139. Johnsons & Johnsons Introduction and Business Overview
Table 140. Johnsons & Johnsons Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Johnsons & Johnsons Calcimimetic Product
Table 142. Johnsons & Johnsons Recent Development
Table 143. Bristol Myers Squibb Company Information
Table 144. Bristol Myers Squibb Introduction and Business Overview
Table 145. Bristol Myers Squibb Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Bristol Myers Squibb Calcimimetic Product
Table 147. Bristol Myers Squibb Recent Development
Table 148. Accord Healthcare , Inc. Company Information
Table 149. Accord Healthcare , Inc. Introduction and Business Overview
Table 150. Accord Healthcare , Inc. Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Accord Healthcare , Inc. Calcimimetic Product
Table 152. Accord Healthcare , Inc. Recent Development
Table 153. Alkem Labs Company Information
Table 154. Alkem Labs Introduction and Business Overview
Table 155. Alkem Labs Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Alkem Labs Calcimimetic Product
Table 157. Alkem Labs Recent Development
Table 158. Viatris Company Information
Table 159. Viatris Introduction and Business Overview
Table 160. Viatris Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Viatris Calcimimetic Product
Table 162. Viatris Recent Development
Table 163. Teva Pharmaceutical Industries Ltd Company Information
Table 164. Teva Pharmaceutical Industries Ltd Introduction and Business Overview
Table 165. Teva Pharmaceutical Industries Ltd Calcimimetic Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Teva Pharmaceutical Industries Ltd Calcimimetic Product
Table 167. Teva Pharmaceutical Industries Ltd Recent Development
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Calcimimetic Market Trends
Table 171. Calcimimetic Market Drivers
Table 172. Calcimimetic Market Challenges
Table 173. Calcimimetic Market Restraints
Table 174. Calcimimetic Distributors List
Table 175. Calcimimetic Downstream Customers
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Calcimimetic Product Picture
Figure 2. Global Calcimimetic Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Calcimimetic Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Calcimimetic Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Cinacalcet
Figure 6. Global Cinacalcet Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Etelcalcetide
Figure 8. Global Etelcalcetide Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Evocalcet
Figure 10. Global Evocalcet Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Calcimimetic Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Calcimimetic Sales Market Share by Type in 2022 & 2029
Figure 13. North America Calcimimetic Sales Market Share in Volume by Type in 2022
Figure 14. North America Calcimimetic Sales Market Share in Value by Type in 2022
Figure 15. Europe Calcimimetic Sales Market Share in Volume by Type in 2022
Figure 16. Europe Calcimimetic Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Calcimimetic Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Calcimimetic Sales Market Share in Value by Type in 2022
Figure 19. Latin America Calcimimetic Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Calcimimetic Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Calcimimetic Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Calcimimetic Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Calcimimetic Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Calcimimetic Revenue in 2022
Figure 25. Calcimimetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Clinic
Figure 29. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Calcimimetic Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Calcimimetic Sales Market Share by Application in 2022 & 2029
Figure 32. North America Calcimimetic Sales Market Share in Volume by Application in 2022
Figure 33. North America Calcimimetic Sales Market Share in Value by Application in 2022
Figure 34. Europe Calcimimetic Sales Market Share in Volume by Application in 2022
Figure 35. Europe Calcimimetic Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Calcimimetic Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Calcimimetic Sales Market Share in Value by Application in 2022
Figure 38. Latin America Calcimimetic Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Calcimimetic Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Calcimimetic Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Calcimimetic Manufacturing Cost Structure
Figure 43. Calcimimetic Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed A calcimimetic is a pharmaceutical drug that mimics the action of calcium on tissues, by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. Calcimimetics are used to treat secondary hyperparathyroidism (SHPT). Calcimimetic report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Calcimimetic market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
The parathyroid gland is an essential gland for human life, and SHPT is a common and serious decompensation disease in patients with chronic kidney disease receiving dialysis treatment, and it is one of the important manifestations of mineral metabolism disorders. According to the 2012 China Epidemiological Survey, the number of patients with middle and end-stage renal disease in China is about 2 million, the dialysis rate is less than 20%, and the conversion rate of SHPT in patients with mineral and bone metabolic disorders (CKD-MBD) is close to 50%. . The dialysis rate is 90% in developed countries (United States, Europe, Japan). Based on this, it can be predicted that in the future, the number of SHPT people will release a large growth space with the improvement of the diagnosis, detection and treatment of chronic kidney disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Calcimimetic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Amgen
Ono Pharmaceutical
Aurobindo Pharma
Roche Holding AG
Lilly
Merck & Co., Inc.
Johnsons & Johnsons
Bristol Myers Squibb
Accord Healthcare , Inc.
Alkem Labs
Viatris
Teva Pharmaceutical Industries Ltd
Segment by Type
Cinacalcet
Etelcalcetide
Evocalcet
Segment by Application
Hospital
Clinic
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Calcimimetic market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Calcimimetic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Calcimimetic industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Calcimimetic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Calcimimetic introduction, etc. Calcimimetic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Calcimimetic market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.
CHOOSE LICENSE TYPE
USD 3350.00
USD 5025.00
USD 6700.00
Add to Cart
Buy Now
Have a question?
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
General Email:
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Have a question?
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
General Email:
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
-
Fastest report delivery service
-
More than 17 years of vast experience
-
Operation for 24 * 7 & 365 days
-
In-depth and comprehensive analysis
-
Professional and timely after-sales service
-
Owns large database
Add to Cart
Buy Now